Bon Natural Life Limited (BON) vs Newmont Corporation (NEM)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BON | NEM | |
|---|---|---|
| Sector | Basic Materials | Basic Materials |
| Industry | Specialty Chemicals | Gold |
| Size band | NANO | LARGE |
| Listing | Nasdaq CM | NYSE |
| Country | China | United States |
| Theme | specialty-chemicals | gold-mining |
| Price and returns | ||
| Last close | $1.17 | $110.39 |
| Return · 1 week | +4.56% | −6.46% |
| Return · 1 month | −4.10% | −4.88% |
| Return · 3 months | +2.63% | +20.62% |
| Return · year to date | −31.58% | +9.54% |
| Return · 1 year | −39.06% | +41.41% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −43.48% | −18.40% |
| 52-week high | $2.07 | $135.29 |
| 52-week low | $0.95 | $76.05 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $9.56M | $114.72B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $6.90K | $701.65M |
| Employees | 96 | 17,500 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 14.86× |
| Price to earnings · forward | 1.99× | 11.62× |
| Price to sales | 0.50× | 4.82× |
| Price to book | 0.14× | 3.54× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 6.82× |
| Enterprise value to revenue | 0.77× | 4.52× |
| PEG ratio | — | 2.78 |
| Earnings per share · trailing | -2.79 | 7.93 |
| Profitability | ||
| Gross margin | 20.77% | 59.07% |
| Operating margin | −82.18% | 51.57% |
| Profit margin | −60.39% | 33.36% |
| Return on equity | −21.76% | 25.91% |
| Return on assets | −7.05% | 15.76% |
| Growth | ||
| Revenue growth | +1.90% | +15.10% |
| Earnings growth | — | +11.40% |
| Balance sheet and payout | ||
| Debt / equity (%) | 25.65 | 15.81 |
| Current ratio | 1.83 | 2.55 |
| Dividend yield | 0.00% | 0.92% |
| Payout ratio | 0.00% | 12.86% |
| Trend and volatility | ||
| RSI · 14 | 55.04 | 39.32 |
| ADX · 14 | 58.01 | 17.41 |
| 50-day average | $1.15 | $121.52 |
| 200-day average | $1.31 | $112.47 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.61% | 3.57% |
The full BON analysis
Everything this table leaves out for Bon Natural Life Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BON argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BON analysisThe full NEM analysis
Everything this table leaves out for Newmont Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NEM argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NEM analysis